FDCDDQ
GPCR icon

Federation des caisses Desjardins du Quebec’s Structure Therapeutics GPCR Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$80.5K Buy
+1,500
New +$66.4K ﹤0.01% 1801
2025
Q3 		– Sell
-20
Closed -$415 – 2933
2025
Q2 		$415 Hold
20
– – ﹤0.01% 2591
2025
Q1 		$346 Hold
20
– – ﹤0.01% 2532
2024
Q4 		$542 Hold
20
– – ﹤0.01% 2381
2024
Q3 		$878 Buy
+20
New +$773 ﹤0.01% 2337

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's GPCR Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec opened a new position in Structure Therapeutics (GPCR) in Q2 2026: 1,500 shares worth $80.5K. The stake represents ﹤0.01% of the portfolio and ranks #1801 among its holdings. This is a return to the name: Federation des caisses Desjardins du Quebec previously reported a position in GPCR as recently as Q2 2025.

Federation des caisses Desjardins du Quebec first reported a position in GPCR in Q3 2024 and has held it in 5 quarters since. 191 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • Federation des caisses Desjardins du Quebec held 1,500 shares of Structure Therapeutics worth $80.5K as of Q2 2026.
  • Structure Therapeutics was a new Federation des caisses Desjardins du Quebec position in Q2 2026.
  • Structure Therapeutics made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #1801 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in Structure Therapeutics in Q3 2024 and has held it in 5 quarters since.
  • 191 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.